Literature DB >> 2542140

Antioxidant properties of conjugated bilirubin and biliverdin: biologically relevant scavenging of hypochlorous acid.

R Stocker1, E Peterhans.   

Abstract

Conjugated bilirubin at low micromolar concentrations strongly inhibits the luminol-enhanced chemiluminescence response of stimulated human polymorphonuclear leukocytes. In contrast, it does not inhibit either reduction of ferricytochrome c or lucigenin-mediated chemiluminescence of stimulated cells. Also, conjugated bilirubin and its metabolic precursor, biliverdin, do not inhibit the enzyme myeloperoxidase (MPO) since (i) the MPO-dependent oxidation of guaiacol is not affected by biliverdin and (ii) the spectral changes observed when conjugated bilirubin is oxidized by a MPO-H2O2-Cl(-)-system are very similar to those obtained with reagent HOCl. As judged from these spectroscopic studies, each molecule of conjugated bilirubin can scavenge one molecule of HOCl giving rise to an oxidation product that itself is capable of scavenging further molecules of HOCl. Importantly, at physiological pH, both bile pigments can efficiently protect the elastase-inhibitory capacity of alpha 1-antiprotease against inactivation by reagent HOCl.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542140     DOI: 10.3109/10715768909073428

Source DB:  PubMed          Journal:  Free Radic Res Commun        ISSN: 8755-0199


  27 in total

1.  Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds.

Authors:  Mona N Rahman; Dragic Vukomanovic; Jason Z Vlahakis; Walter A Szarek; Kanji Nakatsu; Zongchao Jia
Journal:  J R Soc Interface       Date:  2012-11-08       Impact factor: 4.118

2.  Effects of total bilirubin on the prevalence of osteoporosis in postmenopausal women without potential liver disease.

Authors:  Lu-Qin Bian; Rong-Zhen Li; Zheng-Yun Zhang; Yan-Ji Jin; Hyung-Wook Kang; Zhen-Zhu Fang; Youn-Soo Park; Yoon-Ho Choi
Journal:  J Bone Miner Metab       Date:  2013-04-12       Impact factor: 2.626

3.  Usefulness of serum bilirubin levels as a biomarker for long-term clinical outcomes after percutaneous coronary intervention.

Authors:  Hyun-Wook Kim; Dong-Hyun Choi; Leejin Lim; Young-Min Lee; Joon Tae Kang; Seung Seok Chae; Young-Jae Ki; Heesang Song; Young-Youp Koh
Journal:  Heart Vessels       Date:  2014-07-22       Impact factor: 2.037

Review 4.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

5.  Association of Serum Bilirubin with SYNTAX Score and Future Cardiovascular Events in Patients Undergoing Coronary Intervention.

Authors:  Chun-Chin Chang; Chien-Yi Hsu; Po-Hsun Huang; Chia-Hung Chiang; Shao-Sung Huang; Hsin-Bang Leu; Chin-Chou Huang; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

6.  Hypochlorite-induced oxidation of proteins in plasma: formation of chloramines and nitrogen-centred radicals and their role in protein fragmentation.

Authors:  C L Hawkins; M J Davies
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

7.  Bilirubin oxidation products (BOXes): synthesis, stability and chemical characteristics.

Authors:  W L Wurster; G J Pyne-Geithman; I R Peat; J F Clark
Journal:  Acta Neurochir Suppl       Date:  2008

Review 8.  Bilirubin, a Cardiometabolic Signaling Molecule.

Authors:  Terry D Hinds; David E Stec
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

9.  Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival.

Authors:  Yong Wei; Xiao-ming Liu; Kelly J Peyton; Hong Wang; Fruzsina K Johnson; Robert A Johnson; William Durante
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-22       Impact factor: 4.249

10.  Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase.

Authors:  Ghassan J Maghzal; Meng-Choo Leck; Emma Collinson; Cheng Li; Roland Stocker
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.